SCHEMBL22081802

SCHEMBL22081802

Nc1cc(Cl)cc(C2=CCOC2)c1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22032867 0.83 PIK3CA (0.39) TP53CYP3A4
SCHEMBL22081879 0.72 TP53 (0.35) TP53CYP3A4
SCHEMBL30381092 0.72 TP53 (0.35) TP53CYP3A4
SCHEMBL2809035 0.71 CYP3A4 (0.71) TP53CYP3A4
SCHEMBL3506346 0.66 — —
SCHEMBL30142177 0.66 KDM4E (0.33) —
SCHEMBL23275267 0.64 CCR1 (0.31) —
SCHEMBL22032908 0.64 TP53 (0.41) TP53CYP3A4
SCHEMBL24038711 0.64 CYP3A4 (0.35) TP53CYP3A4
SCHEMBL29762456 0.64 CCR1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020117877-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE AQUINNAH PHARMACEUTICALS, INC. (US) 2020-06-11 — — WO disclosed
Send feedback